Composite Grafts, Split-Thickness Grafts, and Free Cartilage Grafts
Composite grafts transfer multiple tissue layers (skin, cartilage, and sometimes mucosa) as a single unit, primarily for nasal alar and auricular reconstruction. Split-thickness skin grafts (STSG) harvest epidermis with variable dermis thickness and are preferred for large or poorly vascularized wound beds. Free cartilage grafts provide structural support without skin coverage.
By Dr. Yehonatan Kaplan (M.D., Fellow ACMS)·Published: 2025-03-01·Updated: 2026-03-15·Reviewed: 2026-03-07
A composite graft is a free graft consisting of two or more tissue types, most commonly skin and cartilage, harvested as a single unit. The most clinically important composite graft in dermatologic surgery combines auricular skin with the underlying conchal or helical cartilage for reconstruction of nasal alar defects involving cartilage loss. Because the graft contains avascular cartilage in its center, composite grafts have the most precarious blood supply of any graft type. They rely entirely on peripheral revascularization from the wound margins. This limits reliable composite graft size to approximately 1.0-1.5 cm in greatest dimension. Larger composite grafts carry a high risk of central necrosis due to insufficient perfusion of the graft core.
Composite Graft Donor Sites and Indications
The ear is the primary donor site for composite grafts used in facial reconstruction. The conchal bowl provides a concave cartilage-skin unit ideal for nasal alar replacement, while the helical root/crus provides a convex unit suitable for alar rim or helical rim reconstruction.
Donor Site
Tissue Composition
Primary Indication
Maximum Reliable Size
Conchal bowl
Skin + conchal cartilage
Nasal alar defects with cartilage loss
1.0-1.5 cm
Helical root/crus
Skin + elastic cartilage (bilaminar)
Alar rim, helical rim defects
1.0-1.5 cm
Helical rim
Anterior skin + cartilage + posterior skin
Full-thickness ear defects
1.0 cm (trilaminar)
Nasal septum (rarely)
Mucosa + septal cartilage
Internal nasal lining + support
Limited by septal anatomy
Composite Graft Healing Sequence
Composite grafts undergo a characteristic color change sequence during the first week that serves as a clinical indicator of graft viability. Recognizing this sequence is essential for appropriate postoperative management and patient reassurance.
Phase 1: Blanching (0-6 hours)
Immediately after placement, the graft appears white/pale due to absence of blood flow. This is normal and expected. The graft is surviving on passive diffusion (imbibition) from the wound bed.
Phase 2: Pale Pink (6-12 hours)
The graft transitions to a pale pink hue as plasmatic imbibition provides initial nutrient exchange. This early pink color is encouraging but does not yet indicate vascular reconnection.
Phase 3: Blue/Venous Congestion (12-72 hours)
The graft often appears dusky blue or violaceous during this phase, reflecting venous congestion. Arterial inflow begins before venous outflow is established, causing transient congestion. This is the most alarming phase for patients and trainees, but it is a normal part of composite graft healing. This phase does NOT indicate graft failure.
Phase 4: Light Pink: Survival (3-7 days)
The graft transitions to a healthy light pink color as both arterial inflow and venous drainage are established through neovascularization. This color indicates graft survival. If the graft remains dusky blue or turns black by day 5-7, partial or complete necrosis should be suspected.
Split-Thickness Skin Grafts (STSG)
A split-thickness skin graft consists of the entire epidermis and a variable portion of the dermis. STSGs are classified by dermal thickness: thin (0.13-0.30 mm, also called Thiersch grafts), medium/intermediate (0.30-0.46 mm), and thick (0.46-0.76 mm). STSGs are harvested using a dermatome (manual or powered) that shaves the skin at a controlled depth. Because they leave behind a dermal remnant at the donor site, the donor wound heals by re-epithelialization from the remaining adnexal structures (hair follicles, eccrine ducts). This is a critical distinction from FTSGs where the donor site requires primary closure.
STSG Thickness Classification
The thickness of an STSG determines its clinical properties and is selected based on the clinical scenario.
Thickness
Range (mm)
Contraction
Take Rate
Cosmesis
Typical Use
Thin (Thiersch)
0.13-0.30
Highest
Highest
Poorest. Shiny, depigmented
Chronic wounds, poor vascular beds, large burns
Medium
0.30-0.46
Moderate
High
Moderate
General coverage, leg ulcers
Thick
0.46-0.76
Lower
Moderate
Better. Approaches FTSG quality
Facial defects when FTSG not possible
FTSG vs. STSG vs. Composite Graft Comparison
Understanding the key differences between graft types is fundamental to selecting the appropriate reconstruction method for each clinical scenario.
Parameter
FTSG
STSG
Composite
Tissue layers
Full epidermis + full dermis
Full epidermis + partial dermis
Skin + cartilage (+/- mucosa)
Nutrition requirement
High
Low (lowest of all grafts)
Highest (avascular cartilage core)
Secondary contraction
Low (5-20%)
High (up to 40-50%)
Minimal (cartilage acts as splint)
Color/texture match
Excellent
Poor. Shiny, atrophic
Good (if well-matched donor)
Maximum reliable size
Limited by donor laxity
Very large (entire thigh)
1.0-1.5 cm
Donor site healing
Primary closure (scar)
Re-epithelialization (10-21 d)
Primary closure
Best recipient bed
Well-vascularized tissue
Any bed (even poor vascularity)
Excellent vascularity required from margins
Primary use in derm surgery
Facial defects post-Mohs
Large/irradiated/chronic wounds
Nasal alar/helical rim with cartilage loss
Structural support
None (skin only)
None (skin only)
Yes (cartilage framework)
Free Cartilage Grafts
Free cartilage grafts provide structural support and architectural framework without a skin component. Cartilage is avascular and derives its nutrition from surrounding perichondrium and overlying soft tissue via diffusion. This property allows cartilage to survive as a free graft in most wound beds. Free cartilage grafts are used to restore contour and prevent collapse in areas where the cartilage framework has been lost during tumor extirpation.
Donor Sites for Free Cartilage
The three primary donor sites for free cartilage grafts are the auricular cartilage (conchal bowl or antihelix), nasal septum, and costal (rib) cartilage. Auricular cartilage is elastic cartilage. Flexible and resilient, ideal for nasal alar support. Nasal septal cartilage is hyaline cartilage. Rigid and flat, useful for dorsal nasal support or columellar struts. Rib cartilage provides the largest quantity and is reserved for major reconstructive cases.
Donor
Cartilage Type
Characteristics
Typical Use
Conchal bowl (ear)
Elastic
Flexible, curved, springs back to shape
Alar batten graft, alar rim support
Auricular helix (ear)
Elastic
Curved, somewhat rigid
Nasal dorsum, alar support
Nasal septum
Hyaline
Rigid, flat, smooth
Columellar strut, dorsal onlay, spreader grafts
Rib (costal)
Hyaline
Large, rigid, tends to warp
Major nasal reconstruction, total framework
Technique Considerations for Composite Grafts
Composite graft success depends on maximizing the graft-recipient contact area and minimizing metabolic demand during the critical revascularization period. The graft should be slightly oversized (10-15%) to account for contraction. Gentle handling is essential. Cartilage should not be crushed with forceps. The graft is sutured with interrupted sutures placing the skin-to-skin and cartilage-to-cartilage interfaces in alignment. Some surgeons advocate fenestrating the skin component to allow drainage and prevent hematoma. The wound bed must be freshened and hemostatic. Postoperatively, cooling with cold compresses for 48-72 hours reduces metabolic demand and has been shown to improve composite graft survival rates. Patients must be strictly counseled to stop smoking for at least 2 weeks before and after surgery.
Complications
Composite graft complications include partial necrosis (most common, especially central necrosis due to inadequate perfusion), complete graft loss, infection, hematoma formation beneath the graft, color mismatch, contour irregularity, and donor site complications (ear deformity if excessive cartilage is harvested). STSG complications include secondary contraction (the most functionally significant), poor cosmetic appearance (shiny, depigmented, atrophic), donor site pain and infection, hypertrophic scarring at the donor site, and pigmentary changes. For cartilage grafts, complications include warping (especially rib cartilage), resorption over time, infection, and visible/palpable edges.